Here’s how wearables are being enlisted to study neurodegenerative diseases

Teva Pharmaceuticals’ collaboration with Intel this week to develop a way to track Huntington’s disease patients through a combined platform of wearables and machine learning platform is a fascinating development. The partnership underscores the pharma industry’s growing interest in using digital health to develop a more complete understanding of patient populations to advance drug development. Neurodegenerative diseases represent a particularly interesting area for wearables to come into play as clinicians and researchers seek to better understand disease progression. The point is to get a fuller picture of patients between doctor appointments. The machine learning component is designed to make sense of the enormous amount of data the study will gather. As part of the sub-study within an ongoing Phase 2 Open-Pride HD Study,  patients will use a smartphone and wear a smartwatch equipped with sensing technology to continuously measure…


Link to Full Article: Here’s how wearables are being enlisted to study neurodegenerative diseases